Prevalence and clinical characteristics of patients with atrial fibrillation: Analysis of 20,000 cases in Japan

Japanese Circulation Journal

Volumn 64, Issue 9, 2000, Pages 653-658

  Tomita, F ^a   Kohya, T ^a   Sakurai, M ^a   Kaji, T ^a   Yokoshiki, H ^a   Sato, M ^a   Sasaki, K ^a   Itoh, Y ^a   Konno, M ^a   Kitabatake, A ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antithrombotic therapy; Aspirin; Nonvalvular atrial fibrillation; Thromboembolism; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CEREBROVASCULAR DISEASE; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHI-SQUARE DISTRIBUTION; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMAN; INCIDENCE; ISCHEMIA; JAPAN; MALE; MIDDLE AGE; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM;

EID: 0033818241     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.64.653     Document Type: Article

References (23)

1. Epidemiologic features of chronic atrial fibrillation: The Framingham study
2. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implication
3. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study
4. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK study
5. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation
6. Stroke prevention in atrial fibrillation study: Final results
7. Canadian atrial fibrillation anticoagulation (CAFA) study
8. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation
9. Warfarin verssus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study
10. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial
11. Management of patients with atrial fibrillation: A statement for the healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association
12. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials
13. The efficacy of aspirin in patients with atrial fibrillation: Analysis of pooled data from 3 randomized trials
14. The risk of cerebral infarction in non-valvular atrial fibrillation: Effects of age, hypertension and antihypertensive treatment
15. Ischemic cerebrovascular disease in patients with atrial fibrillation
16. COOPAT (Cooperative Osaka Platelet Antiaggregation Trial) study
17. Atrial fibrillation and thromboembolism: A multicenter cooperative study
18. Collaborative overview of randomized trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
19. Final report on the aspirin component of the ongoing Physicians' Health Study
20. Assessment of left atrial appendage function by biplane transesophageal echocardiography in patients with nonrheumatic atrial fibrillation: Identification of a subgroup of patients at increased embolic risk
21. Assessment of left atrial appendage function by transesophageal echocardiography: Implication for the development of thrombus
22. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation
23. Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation: Stroke Prevention in Atrial fibrillation Investigators